Pancreatic acinar cell damage induced by 4-nitroquinoline-1-oxide and 4-hydroxyaminoquinoline-1-oxide.
D000818:Animals; D003497:Cyclic N-Oxides / Q000008:administration & dosage / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D006898:Hydroxylamines / Q000008:administration & dosage / Q000633:toxicity; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008099:Liver / Q000187:drug effects; D008297:Male; D009336:Necrosis; D009574:Nitro Compounds / Q000008:administration & dosage / Q000633:toxicity; D010179:Pancreas / Q000187:drug effects* / Q000473:pathology; D010182:Pancreatic Diseases / Q000139:chemically induced* / Q000473:pathology; D011804:Quinolines / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D012469:Salivary Glands / Q000187:drug effects; D013997:Time Factors
D003497:Cyclic N-Oxides; D006898:Hydroxylamines; D009574:Nitro Compounds; D011804:Quinolines